Literature DB >> 29730651

An Intersectional Study of LncRNAs and mRNAs Reveals the Potential Therapeutic Targets of Buyang Huanwu Decoction in Experimental Intracerebral Hemorrhage.

Hanjin Cui1, Tao Liu1,2, Pengfei Li1, Ali Yang3,4, Huajun Zhou5, Jiekun Luo1, En Hu1, Wang Hu1, Yang Wang1, Tao Tang1.   

Abstract

BACKGROUND/AIMS: Both experimental and clinical studies have revealed satisfactory effects of the traditional Chinese formula Buyang Huanwu decoction (BYHWD) in improving post-intracerebral hemorrhage (ICH) neurological deficiencies. However, the multifaceted mechanisms of BYHWD in ICH treatment are not comprehensively understood. The present study explored various therapeutic targets of BYHWD by using lncRNA and mRNA transcriptomics.
METHODS: LncRNA and mRNA microarrays were used to identify differentially expressed genes. ICH-induced upregulated genes (ICH vs sham) and BYHWD-induced downregulated genes (BYHWD vs ICH) were first identified. The intersection between these 2 sets was determined to identify ICH-induced highly expressed genes that were reversed by BYHWD. Then, the genes downregulated after ICH and the genes upregulated after BYHWD treatment were used to generate another set of intersections. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway analyses were subsequently performed to determine relative biological functions and signaling transduction pathways according to genes within the intersections. Quantitative real-time PCR was used to validate changes in gene expression observed using the microarray. Finally, a lncRNA-mRNA co-expression network was established to identify links among the genes within the intersections.
RESULTS: A total of 18 differentially expressed lncRNAs and 33 differentially expressed mRNAs were identified using 2 lncRNA arrays (ICH vs sham and BYHWD vs ICH). The altered genes were enriched in the hemoglobin complex, oxygen transport and oxygen transporter and were closely associated with pyruvate metabolism. The co-expression network consisted of 53 nodes and 595 connections (308 positive interactions and 287 negative interactions).
CONCLUSION: The hemoglobin complex, oxygen transport, oxygen transporter activity and pyruvate metabolism are possible therapeutic targets of BYHWD in ICH treatment. The present study provides the basis and direction for future investigations to explore the mechanisms by which BYHWD protects against long-term neurological deficiencies after ICH.
© 2018 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Expression profile; Intersectional study; Intracerebral hemorrhage; Long non-coding RNA (lncRNA); Messenger RNA (mRNA)

Mesh:

Substances:

Year:  2018        PMID: 29730651     DOI: 10.1159/000489547

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  7 in total

1.  Long noncoding RNA XIST participates hypoxia-induced angiogenesis in human brain microvascular endothelial cells through regulating miR-485/SOX7 axis.

Authors:  Chenggong Hu; Xue Bai; Chang Liu; Zhi Hu
Journal:  Am J Transl Res       Date:  2019-10-15       Impact factor: 4.060

2.  Buyang Huanwu Decoction Exerts Cardioprotective Effects through Targeting Angiogenesis via Caveolin-1/VEGF Signaling Pathway in Mice with Acute Myocardial Infarction.

Authors:  Jia-Zhen Zhu; Xiao-Yi Bao; Qun Zheng; Qiang Tong; Peng-Chong Zhu; Zhuang Zhuang; Yan Wang
Journal:  Oxid Med Cell Longev       Date:  2019-04-16       Impact factor: 6.543

3.  Systematic Analysis of tRNA-Derived Small RNAs Reveals Novel Potential Therapeutic Targets of Traditional Chinese Medicine (Buyang-Huanwu-Decoction) on Intracerebral Hemorrhage.

Authors:  Pengfei Li; Tao Tang; Tao Liu; Jing Zhou; Hanjin Cui; Zehui He; Yuanyuan Zhong; En Hu; Ali Yang; Gaohui Wei; Jiekun Luo; Yang Wang
Journal:  Int J Biol Sci       Date:  2019-03-01       Impact factor: 6.580

4.  Optimal intervention time and risk of the activating blood and removing stasis method in acute cerebral hemorrhage patients: A randomized placebo-controlled trial.

Authors:  Ying Ma; Dongmei Zhang; Zhiguo Lv; Yabin Cui; Yutong Fei; Tianying Chang; Mingkun Yu; Jing Lu; Qingxia Huang; Ying Zhang; Peng Xu; Tianye Lan; Jian Wang
Journal:  Medicine (Baltimore)       Date:  2021-01-15       Impact factor: 1.817

5.  Buyang Huanwu Decoction Enhances Revascularization via Akt/GSK3β/NRF2 Pathway in Diabetic Hindlimb Ischemia.

Authors:  Xiao-Yi Bao; Li-Hui Deng; Zi-Jun Huang; Abdirizak S Daror; Zi-Hao Wang; Wang-Jun Jin; Zhuang Zhuang; Qiang Tong; Guo-Qing Zheng; Yan Wang
Journal:  Oxid Med Cell Longev       Date:  2021-12-03       Impact factor: 6.543

6.  Uncovering the potential mechanism of Xue Fu Zhu Yu Decoction in the treatment of intracerebral hemorrhage.

Authors:  Dao-Jin Xue; Zheng Zhen; Ke-Xin Wang; Jia-Lin Zhao; Yao Gao; Yu-Peng Chen; You-Bi Shen; Zi-Zhuang Peng; Dao-Gang Guan; Tao Huang
Journal:  BMC Complement Med Ther       Date:  2022-04-12

7.  An intersectional analysis of LncRNAs and mRNAs reveals the potential therapeutic targets of Bi Zhong Xiao Decoction in collagen-induced arthritis rats.

Authors:  Cailin He; Yang Wang; Yuqi Wen; Teng Li; En Hu; Siqing Zeng; Bo Yang; Xingui Xiong
Journal:  Chin Med       Date:  2022-09-16       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.